<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/44281153-8D26-4240-8D53-50B1781E71AE"><gtr:id>44281153-8D26-4240-8D53-50B1781E71AE</gtr:id><gtr:name>Marie Sklodowska-Curie Actions</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0C45EF60-D5E5-4E71-8AD4-5EDE8AD48494"><gtr:id>0C45EF60-D5E5-4E71-8AD4-5EDE8AD48494</gtr:id><gtr:name>Dibrugarh University</gtr:name><gtr:address><gtr:line1>Dibrugarh University</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Pharmaceutical Sciences</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/44281153-8D26-4240-8D53-50B1781E71AE"><gtr:id>44281153-8D26-4240-8D53-50B1781E71AE</gtr:id><gtr:name>Marie Sklodowska-Curie Actions</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0C45EF60-D5E5-4E71-8AD4-5EDE8AD48494"><gtr:id>0C45EF60-D5E5-4E71-8AD4-5EDE8AD48494</gtr:id><gtr:name>Dibrugarh University</gtr:name><gtr:address><gtr:line1>Dibrugarh University</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CE8DA1F4-C27B-41D3-9F03-2A183EA393F3"><gtr:id>CE8DA1F4-C27B-41D3-9F03-2A183EA393F3</gtr:id><gtr:name>CNRS</gtr:name><gtr:address><gtr:line1>1919 Route de Mende</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FAD72F10-05DD-4B4D-89F4-0475C2A79E10"><gtr:id>FAD72F10-05DD-4B4D-89F4-0475C2A79E10</gtr:id><gtr:name>School of Pharmacy</gtr:name><gtr:address><gtr:line1>29-39 Brunswick Square</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1N 1AX</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/509FBD0D-BA30-4015-B269-33698EA4F05A"><gtr:id>509FBD0D-BA30-4015-B269-33698EA4F05A</gtr:id><gtr:firstName>Khuloud</gtr:firstName><gtr:otherNames>T</gtr:otherNames><gtr:surname>Al-Jamal</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FJ008656%2F1"><gtr:id>E2892449-212D-441E-8458-B0E61C3EA2D5</gtr:id><gtr:title>Shuttling through the Blood Brain Barrier using Carbon Nanoneedles</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/J008656/1</gtr:grantReference><gtr:abstractText>A significant proportion of the population are affected by diseases of the brain, many of which have limited drug treatment. Such diseases are often difficult to clinically diagnose and treat due to the limitations of brain access. One of the principle obstacles in drug development is brain delivery of the drugs or imaging agents, that can treat the disease or enhance its diagnosis. Recently, ultra small tubular like nanomaterial made of carbon called carbon nanotubes has been developed which could serve as &amp;quot;rafts&amp;quot; that could help transport drugs into the brain or could facilitate imaging of the brain. However, at present there is lack of information about the ability and mechanisms by which these nanotubes can penetrate into the brain through the blood brain barrier. This project will utilise a cellular model of this tight membrane to investigate how these nanotubes cross the endothelial brain membrane and whether they affect its integrity.</gtr:abstractText><gtr:technicalSummary>Targeted drug delivery across the blood brain barrier (BBB) to the central nervous system is a large challenge for the treatment of neurological disorders. Drug delivery systems that cross the BBB without disrupting it would also have many applications for brain cancer diagnostic and other diseases, e.g. Alzheimer's disease. There still remains a pressing need for improved nanoparticle delivery systems to target drugs across the BBB. Functionalized carbon nanotubes (CNTs) are receiving increasing attention as vehicles for the delivery of diagnostic and therapeutic agents. The delivery properties of CNTs derive from the potential to deliver a drug by heterogeneously functionalizing their surface and also their ability to traverse the plasma membrane, promoting the cellular uptake of small molecules. However, there is essentially no mechanistic data at the level of individual CNTs to characterise their fundamental interaction with endothelial cells or how this interaction is modified by CNT surface chemistry and targeting to specific BBB receptors such as transferrin receptor or low density lipoprotein receptor-related protein 1. This project aims towards the evaluation of the BBB penetration capacity of novel f-CNT carriers using an in vitro BBB model employing porcine brain endothelial cells (PBECs) chosen due to its high transendothelial electrical resistance when cultured as a monolayer without astrocytes (&amp;gt;300 ohm.cm2) and good expression of the most important drug efflux transporters and P-glycoprotein. f-CNT will be fluorescently labelled or conjugated to a radioactive tracer to allow for qualitative and quantitative measurement of uptake or BBB permeation. Insights into these mechanisms will be essential to guide the development of CNT vectors to deliver drugs across the BBB to the central nervous system for the treatment of neurological disorders.</gtr:technicalSummary><gtr:potentialImpactText>This project will have an impact in academia and industry and will address all those interested in brain delivery, blood brain barrier biology and nanomedicine. Such a collaborative project promises to bring about a long-term benefit to the development of UK and European science and its clinical translation. It is relevant to pharmaceutical and medical companies interested in developing novel therapeutic approaches to the brain. The research aims to improve and expand brain delivery options to enhance the quality of life for UK and European citizens. It has the potential to contribute to knowledge transfer among the different national and European collaborators who are experts in their field. The development of nanopharmaceuticals is an emerging multidisciplinary area and research within a multidisciplinary team is mandatory for progress in the field. It is expected that a number of additional national, EU or independently funded collaborative projects will follow the developments achieved by this project. After fundamental understanding of how permeation processes take place, future funding for further clinical testing and commercialisation of the novel nanotube-based brain delivery systems along will be sought along with an industrial partner. Two highly skilled PDRA researchers will result from this work, ripe for employment in pre-clinical, clinical, industrial, or academic sector.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-03-11</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-03-12</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>452528</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Dibrugarh University</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:description>UKEIRI-DST</gtr:description><gtr:id>D5015C7B-6BA7-4074-8B4D-A062E9BF1DC5</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>565701a10f8392.23599367-1</gtr:outcomeId><gtr:partnerContribution>They provided solid lipid nanoparticles to our team and also will host 3 members of UK team to visit their lab.</gtr:partnerContribution><gtr:piContribution>This scheme is established between KCL (UK partner) and Dibrugarh University (India) to work on the project entitled &amp;quot;Development of biodegradable CNS-targeted nanoparticles as a novel therapeutic approach in chemotherapy of Neuro-AIDS&amp;quot;. KCL contribution has been to train young researchers on optimisation of the nanoparticles formulation, radiolabeling, testing blood brain barrier crossing in vitro and in vivo, in addition to tumour accumulation studies in mice.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Marie Sklodowska-Curie Actions</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Marie Curie Actions ITN FP7 PEOPLE</gtr:description><gtr:id>9A04BB0F-0059-4DB5-94FA-DE3B899CED94</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>565717e428ba02.08304354-1</gtr:outcomeId><gtr:partnerContribution>Synthesis, functionalisation and characterisation of samarium filled carbon nanotubes.</gtr:partnerContribution><gtr:piContribution>In vivo biodistribution and tumour therapy studies of samarium filled carbon nanotubes in mice.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Nanomedicine Summer School</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DE422D77-C583-4FF4-AD9A-5395E96D2E89</gtr:id><gtr:impact>The Marie Curie Early Stage Researcher, Dr Rebecca Klippstein, presented her work entitled 'Assesment of candidate drugs and cell lines for nanoparticle specific tumour targeting'.

EU contribution</gtr:impact><gtr:outcomeId>546c9ce9ea3b98.14880438</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NanoFar Autumn School</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0BE94923-B9C6-4935-A025-D7284DA4F423</gtr:id><gtr:impact>My PhD student Naomi Hodgins attended this Autumn School workshop and had a poster presentation entitled 'Novel ErbB targeted liposomes encapsulating zoledronic acid for breast cancer immunotherapy'.

EU contribution.</gtr:impact><gtr:outcomeId>546c94106ec382.33540131</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NanoFar Autumn School</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3194FE98-0AEE-4CB0-82BD-2504BC540887</gtr:id><gtr:impact>My PhD student Jie Bai attended this Autumn School workshop and presented a poster entitled 'Polymeric Nanocapsule for Triple-modal Imaging as A Theranostic System in Cancer Therapy'. She was awarded the Best Poster prize.

EU contribution.</gtr:impact><gtr:outcomeId>546c949b789768.10618797</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>COST Action TD1004 Annual meeting in Belgrade, Serbia, 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1DE060A8-7A75-49C6-910A-036940C95739</gtr:id><gtr:impact>My PhD students Naomi Hodgins and Jie Bai gave 2 talks:

1. The effect of Liposomal Zoledronic acid on the Biodistribution of ?d T cells in different tumour models&amp;quot;. 
2. Multi-modal imaging of magnetic nanocapsules in tumours

Talks attracted interest and stimulated questions that are helpful for their PhD project.

EU contribution and further opportunities to Horizon 2020 funding</gtr:impact><gtr:outcomeId>565706f29ba5b4.91502910</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nanomedicine Summer School</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7D861941-8DD5-407F-AAD7-7651E19646EB</gtr:id><gtr:impact>Elzbieta Pach, a Marie Curie Early Stage Researcher, of my collaborator Dr Ballesteros in Spain, gave a presentation entitled 'Electron Microscopy Studies of Carbon Nanocapsules for Targeted Delivery of Radioactivity' based on our joint project. Laura Cabana, a PhD student of my collaborator Dr Tobias in Spain, gave a presentation entitled 'Multi-Walled Carbon Nanotubes with different lengths decorated with SPION' based on our joint project. The Marie Curie Early Stage Researcher, Maxime Bourgognon, from my group gave a presentation entitled 'The shortening of SPION-MWNTs enhances their biocompatibility and MR properties'.

EU contribution.</gtr:impact><gtr:outcomeId>546c977b2075f2.08385354</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Queen's University Invited Talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6434242D-83C3-46C6-B9FE-57860D4C9D1E</gtr:id><gtr:impact>I gave a talk on &amp;quot;Uptake of chemically functionalised nanotubes across the blood brain barrier at Queen's University, Belfast. I was invited by Prof. Ryan Donnelly the leader of the Research Seminar Programme at Queen's.
 
They invite leading scientists from across the globe to visit the University and give a seminar on their work. Over the past few years, other renowned speakers like Richard Guy, Kevin Shakesheff, Clive Wilson and Robert Lochhead (inventor of Carbopol&amp;reg;, designed surfactant formulations for management of the oil spill in the gulf of New Mexico and heat-resistant camouflage for soldiers in Iraq and Afghanistan) speak about their research.


The talk stimulated discussions and initiated collaborations between the 2 universities.</gtr:impact><gtr:outcomeId>5470795a2ddc96.89412139</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>AICR Open Day @ Kings College London</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7BC2F7AD-5244-4293-8B54-2B231D88BE75</gtr:id><gtr:impact>I gave a presentation on the research carried out from my group. In the hands-on session, my research team demonstrated how to purify nanoparticles by the size and provided a microscope for cancer tissue observation.

Numerous attendees of the event commented that the quality of the research presented, the enthusiasm of participants and the overall positive buzz made it an enjoyable afternoon. Undergraduate students in particular contributed to the day and felt the importance of research which they never realised before.</gtr:impact><gtr:outcomeId>546e3ad9957008.22273293</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>10200</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Newton-Bhabha Fellowship</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:id>6AFF2D32-EC78-4B6A-8A87-4610F4528217</gtr:id><gtr:outcomeId>58c8458977f859.96883020</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>58000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>KC Wong Postdoctoral Fellowship</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>King's College London</gtr:fundingOrg><gtr:id>8D205B47-9D36-4C51-9FA9-5B003D7FBEEE</gtr:id><gtr:outcomeId>58c8453dcb9119.28634734</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>98000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>New Ideas Awards</gtr:description><gtr:end>2018-06-02</gtr:end><gtr:fundingOrg>The Brain Tumour Charity</gtr:fundingOrg><gtr:id>3578B3E8-AC1E-4923-B4FD-48BA2A32CD4D</gtr:id><gtr:outcomeId>58c84471845598.18959932</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>183455</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Marie Sklodowska-Curie individual Fellowships</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>B800AC23-AF30-4D19-8C9D-8A2C0D8FA404</gtr:id><gtr:outcomeId>58c845eb5a59a1.21835640</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>145650</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Katip Celebi Newton Fund</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:id>EC6CC4E3-BA20-4188-B41F-2ACA8DE686C6</gtr:id><gtr:outcomeId>58c848e81b2a46.57965690</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>22128</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UKEIRI-DST</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:fundingRef>UKIERI-DST-2014-15-09</gtr:fundingRef><gtr:id>6E4A511F-2893-472A-B9A5-26F5C7D4F9E5</gtr:id><gtr:outcomeId>5656febf330262.08216830</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>12800</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Newton Bhabha</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:fundingRef>N/A</gtr:fundingRef><gtr:id>32E3B9FF-CE81-4E4D-B7E7-55743307ADD1</gtr:id><gtr:outcomeId>5656ff343b8e53.41467231</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Research Training Fellowship</gtr:department><gtr:description>Sir Henry Wellcome Postdoctoral Fellowship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>2C55763D-DA66-4E11-920E-0FA527F0BA00</gtr:id><gtr:outcomeId>54653531de2d57.84713253</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>BBSRC Impact Award</gtr:department><gtr:description>BBSRC Spark Impact</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>N/A</gtr:fundingRef><gtr:id>F4615CDD-0E12-40BB-B0F0-83C10780F9C8</gtr:id><gtr:outcomeId>5656ff818f1260.40815167</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The discovery cover a type of polymeric nanoparticles containing high amounts of magnetic nanoparticles for the purpose of magnetic targeting of anticancer drugs to solid tumours. The nanoparticles could be used for therapy and/or imaging.</gtr:description><gtr:grantRef>BB/J008656/1</gtr:grantRef><gtr:id>AF036366-8931-438A-A691-22A16A068438</gtr:id><gtr:impact>Too early.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>56570405ef5f75.80402609</gtr:outcomeId><gtr:patentId>British Patent Application No. 1520637.8</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Nanoparticles</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>Angiopep peptide conjugating to CNT increased the brain uptake and resulted in glioma targeting in mouse brain following intravenous injection.</gtr:description><gtr:exploitationPathways>Further incorporation with therapeutic agents using the developed nanocarrier system can be explored for glioma therapy.</gtr:exploitationPathways><gtr:id>D9BB27E1-DB82-4729-A92B-BA728EA9113F</gtr:id><gtr:outcomeId>56d6e93003abe7.67346796</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>48B777C8-0FDE-496F-94E1-D49911699A02</gtr:id><gtr:title>Investigating in vitro and in vivo av?6 integrin receptor-targeting liposomal alendronate for combinatory ?d T cell immunotherapy.</gtr:title><gtr:parentPublicationTitle>Journal of controlled release : official journal of the Controlled Release Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa5447385c796a5ef8e33404f06df375"><gtr:id>fa5447385c796a5ef8e33404f06df375</gtr:id><gtr:otherNames>Hodgins NO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0168-3659</gtr:issn><gtr:outcomeId>5a2fcde27ee8c2.21299596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6220F934-7A3A-433C-8ABD-73EA6DC7DCC4</gtr:id><gtr:title>Multiphoton luminescence imaging of chemically functionalized multi-walled carbon nanotubes in cells and solid tumors.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/977d58cc6b4175b5b854f5922c217c4f"><gtr:id>977d58cc6b4175b5b854f5922c217c4f</gtr:id><gtr:otherNames>Rubio N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>5645e4aa1385b5.80227732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3F0A069-7712-423B-97EF-169F16DACBD5</gtr:id><gtr:title>Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo.</gtr:title><gtr:parentPublicationTitle>Small (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11a7e57b3be7df68a60d578d98038f1f"><gtr:id>11a7e57b3be7df68a60d578d98038f1f</gtr:id><gtr:otherNames>Klippstein R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1613-6810</gtr:issn><gtr:outcomeId>5645e6663feb75.70680031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01B03501-C00C-4698-8A3E-0D960C79CBA6</gtr:id><gtr:title>Nano-technology based carriers for nitrogen-containing bisphosphonates delivery as sensitisers of ?d T cells for anticancer immunotherapy.</gtr:title><gtr:parentPublicationTitle>Advanced drug delivery reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa5447385c796a5ef8e33404f06df375"><gtr:id>fa5447385c796a5ef8e33404f06df375</gtr:id><gtr:otherNames>Hodgins NO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0169-409X</gtr:issn><gtr:outcomeId>5aaa474501d802.15517125</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C3F1127-9B4B-4198-9401-053115D2A1FC</gtr:id><gtr:title>The Shortening of MWNT-SPION Hybrids by Steam Treatment Improves Their Magnetic Resonance Imaging Properties In Vitro and In Vivo.</gtr:title><gtr:parentPublicationTitle>Small (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ec1f4bb55af1d9c43b9140b79ddc377"><gtr:id>3ec1f4bb55af1d9c43b9140b79ddc377</gtr:id><gtr:otherNames>Cabana L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1613-6810</gtr:issn><gtr:outcomeId>585d33588be9a7.81502237</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD97D19B-9EE2-4557-BF0F-DFFB645B311F</gtr:id><gtr:title>Synthesis of double-clickable functionalised graphene oxide for biological applications.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44dc7a52944d859e29834fdc1bcca804"><gtr:id>44dc7a52944d859e29834fdc1bcca804</gtr:id><gtr:otherNames>Mei KC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>5645e752cf2009.92268723</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7503AAA-29E5-4C45-A956-0C468BC09A4A</gtr:id><gtr:title>Real-time monitoring of magnetic drug targeting using fibered confocal fluorescence microscopy.</gtr:title><gtr:parentPublicationTitle>Journal of controlled release : official journal of the Controlled Release Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5922358760556e34389b31a9ca51381f"><gtr:id>5922358760556e34389b31a9ca51381f</gtr:id><gtr:otherNames>Bai J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-3659</gtr:issn><gtr:outcomeId>585d35a88395c7.84220030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9CD4AC0-4C26-46D6-8B04-ABFCC1B0F8DF</gtr:id><gtr:title>Magnetic Drug Targeting: Preclinical in Vivo Studies, Mathematical Modeling, and Extrapolation to Humans.</gtr:title><gtr:parentPublicationTitle>Nano letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb5d65786130fa33d5c7db8a4e025b56"><gtr:id>eb5d65786130fa33d5c7db8a4e025b56</gtr:id><gtr:otherNames>Al-Jamal KT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1530-6984</gtr:issn><gtr:outcomeId>585d37912a13a3.52604227</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34CAE855-6CDE-403C-97DE-EDB6E54398E3</gtr:id><gtr:title>Solvent-Free Click-Mechanochemistry for the Preparation of Cancer Cell Targeting Graphene Oxide.</gtr:title><gtr:parentPublicationTitle>ACS applied materials &amp; interfaces</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/977d58cc6b4175b5b854f5922c217c4f"><gtr:id>977d58cc6b4175b5b854f5922c217c4f</gtr:id><gtr:otherNames>Rubio N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1944-8244</gtr:issn><gtr:outcomeId>5645e6a5026d93.85428131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE0075AD-81D4-4227-AEAE-074ED2699035</gtr:id><gtr:title>Polyethylene glycol conjugated polymeric nanocapsules for targeted delivery of quercetin to folate-expressing cancer cells in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>ACS nano</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/684382ae0f1b80ad865f0cce0ff393f7"><gtr:id>684382ae0f1b80ad865f0cce0ff393f7</gtr:id><gtr:otherNames>El-Gogary RI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1936-0851</gtr:issn><gtr:outcomeId>5446633869bbf8.50078397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E775B023-D09B-457F-8967-A459BA63B57F</gtr:id><gtr:title>Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood-brain barrier in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of controlled release : official journal of the Controlled Release Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d17406c578d448d77e1ad66ef0eb39f"><gtr:id>9d17406c578d448d77e1ad66ef0eb39f</gtr:id><gtr:otherNames>Kafa H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-3659</gtr:issn><gtr:outcomeId>585d723aea0dd2.05717569</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA11F3F4-24FF-4B42-92B4-CC0412F4E097</gtr:id><gtr:title>Ammonium and guanidinium dendron-carbon nanotubes by amidation and click chemistry and their use for siRNA delivery.</gtr:title><gtr:parentPublicationTitle>Small (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebcf7bfe98f17b46390e7a0ea32d86f2"><gtr:id>ebcf7bfe98f17b46390e7a0ea32d86f2</gtr:id><gtr:otherNames>Battigelli A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1613-6810</gtr:issn><gtr:outcomeId>54468e37f20a37.71519220</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFA49441-52DB-4BB2-984B-7E337675D499</gtr:id><gtr:title>The relationship between the diameter of chemically-functionalized multi-walled carbon nanotubes and their organ biodistribution profiles in vivo.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c77de6f25ddbd82e1ab5917a13a35f63"><gtr:id>c77de6f25ddbd82e1ab5917a13a35f63</gtr:id><gtr:otherNames>Wang JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>54468e37bce6c5.61568762</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EEF3212-AFB4-4403-8891-389E6C1B4AEB</gtr:id><gtr:title>Organic Solvent-Free, One-Step Engineering of Graphene-Based Magnetic-Responsive Hybrids Using Design of Experiment-Driven Mechanochemistry.</gtr:title><gtr:parentPublicationTitle>ACS applied materials &amp; interfaces</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44dc7a52944d859e29834fdc1bcca804"><gtr:id>44dc7a52944d859e29834fdc1bcca804</gtr:id><gtr:otherNames>Mei KC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1944-8244</gtr:issn><gtr:outcomeId>5645e72353f286.10596610</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A25E9E8D-4A23-45B1-A9CC-6EFBB99C6BD3</gtr:id><gtr:title>Carbon nanotubes' surface chemistry determines their potency as vaccine nanocarriers in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of controlled release : official journal of the Controlled Release Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c23c308038779d6077fc6d042aea6ae"><gtr:id>5c23c308038779d6077fc6d042aea6ae</gtr:id><gtr:otherNames>Hassan HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-3659</gtr:issn><gtr:outcomeId>585d725323ed81.53881174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A83AA2C-5CA3-424D-AAFF-DB0F5ACEFC67</gtr:id><gtr:title>Peptide-based carbon nanotubes for mitochondrial targeting.</gtr:title><gtr:parentPublicationTitle>Nanoscale</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebcf7bfe98f17b46390e7a0ea32d86f2"><gtr:id>ebcf7bfe98f17b46390e7a0ea32d86f2</gtr:id><gtr:otherNames>Battigelli A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2040-3364</gtr:issn><gtr:outcomeId>5675d8a3ca5e5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAFCC4DD-0612-4317-BD1D-FD5B872181CE</gtr:id><gtr:title>Spatially-resolved profiling of carbon nanotube uptake across cell lines.</gtr:title><gtr:parentPublicationTitle>Nanoscale</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2da9a466ef8f81a3d564d58117778c2c"><gtr:id>2da9a466ef8f81a3d564d58117778c2c</gtr:id><gtr:otherNames>Summers HD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2040-3364</gtr:issn><gtr:outcomeId>5a2faf0fd928d6.63752575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A681F07A-3411-4A89-86A2-FD0D0E83B335</gtr:id><gtr:title>Correction to &amp;quot;Production of water-soluble few-layer graphene mesosheets by dry milling with hydrophobic drug&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Langmuir : the ACS journal of surfaces and colloids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/977d58cc6b4175b5b854f5922c217c4f"><gtr:id>977d58cc6b4175b5b854f5922c217c4f</gtr:id><gtr:otherNames>Rubio N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0743-7463</gtr:issn><gtr:outcomeId>5645e6fce55dc8.21666127</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05E28162-9269-4DA9-8303-B343AD22350F</gtr:id><gtr:title>Current Perspective of Carbon Nanotubes Application in Neurology.</gtr:title><gtr:parentPublicationTitle>International review of neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d17406c578d448d77e1ad66ef0eb39f"><gtr:id>9d17406c578d448d77e1ad66ef0eb39f</gtr:id><gtr:otherNames>Kafa H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:isbn>9780128046364</gtr:isbn><gtr:issn>0074-7742</gtr:issn><gtr:outcomeId>58c843172aa227.09360246</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>407941AD-E332-4DD1-B326-C443380839C0</gtr:id><gtr:title>Magnetically Decorated Multi-Walled Carbon Nanotubes as Dual MRI and SPECT Contrast Agents.</gtr:title><gtr:parentPublicationTitle>Advanced functional materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c77de6f25ddbd82e1ab5917a13a35f63"><gtr:id>c77de6f25ddbd82e1ab5917a13a35f63</gtr:id><gtr:otherNames>Wang JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1616-301X</gtr:issn><gtr:outcomeId>5675e70b37aea</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B97E1119-7BAF-4785-AB1E-4418561F970E</gtr:id><gtr:title>The interaction of carbon nanotubes with an in vitro blood-brain barrier model and mouse brain in vivo.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d17406c578d448d77e1ad66ef0eb39f"><gtr:id>9d17406c578d448d77e1ad66ef0eb39f</gtr:id><gtr:otherNames>Kafa H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>5645e4cbd39143.56734205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDFD2237-5947-4AA4-90D9-D79F94258DD7</gtr:id><gtr:title>Functionalised carbon nanotubes: From intracellular uptake and cell-related toxicity to systemic brain delivery.</gtr:title><gtr:parentPublicationTitle>Journal of controlled release : official journal of the Controlled Release Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9ede182fb5d0b252c4e32e56f805aa2"><gtr:id>e9ede182fb5d0b252c4e32e56f805aa2</gtr:id><gtr:otherNames>Costa PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-3659</gtr:issn><gtr:outcomeId>585d35afd94612.10417012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4F4089A-2D2E-4881-BC4D-33E16958BF50</gtr:id><gtr:title>Engineering hepatitis B virus core particles for targeting HER2 receptors in&amp;nbsp;vitro and in&amp;nbsp;vivo.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bfc6917a28b242f22d9a0313d462d90"><gtr:id>2bfc6917a28b242f22d9a0313d462d90</gtr:id><gtr:otherNames>Mohamed Suffian IFB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>58c842347ba014.28033044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66EA9A08-3F41-4EF7-974A-B1945576D94C</gtr:id><gtr:title>Yield Optimisation of Hepatitis B Virus Core Particles in E. coli Expression System for Drug Delivery Applications.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4549218f35810c13dd9aae945fc71398"><gtr:id>4549218f35810c13dd9aae945fc71398</gtr:id><gtr:otherNames>Bin Mohamed Suffian IF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c842a74dc614.54402941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D015A13-F756-40DD-B3B5-FB95B2985F50</gtr:id><gtr:title>How do functionalized carbon nanotubes land on, bind to and pierce through model and plasma membranes.</gtr:title><gtr:parentPublicationTitle>Nanoscale</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a789eb6759104b9b66b67e55bc1c204d"><gtr:id>a789eb6759104b9b66b67e55bc1c204d</gtr:id><gtr:otherNames>Lacerda L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2040-3364</gtr:issn><gtr:outcomeId>5675d8e065520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7273F241-8E15-491F-8F51-1EDC51C91CD6</gtr:id><gtr:title>In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with &amp;Icirc;&amp;sup3;&amp;Icirc;&amp;acute; T cell immunotherapy in mice.</gtr:title><gtr:parentPublicationTitle>Journal of controlled release : official journal of the Controlled Release Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa5447385c796a5ef8e33404f06df375"><gtr:id>fa5447385c796a5ef8e33404f06df375</gtr:id><gtr:otherNames>Hodgins NO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-3659</gtr:issn><gtr:outcomeId>585d35ab384451.87696247</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29B79DBE-0067-4A3E-8970-07CEFC3EB5DF</gtr:id><gtr:title>Triple-Modal Imaging of Magnetically-Targeted Nanocapsules in Solid Tumours In Vivo.</gtr:title><gtr:parentPublicationTitle>Theranostics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5922358760556e34389b31a9ca51381f"><gtr:id>5922358760556e34389b31a9ca51381f</gtr:id><gtr:otherNames>Bai J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1838-7640</gtr:issn><gtr:outcomeId>5a35b1454ea621.55365554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F86D551F-1A80-48DA-82BC-64BB2898E4A8</gtr:id><gtr:title>Kinetics of functionalised carbon nanotube distribution in mouse brain after systemic injection: Spatial to ultra-structural analyses.</gtr:title><gtr:parentPublicationTitle>Journal of controlled release : official journal of the Controlled Release Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c77de6f25ddbd82e1ab5917a13a35f63"><gtr:id>c77de6f25ddbd82e1ab5917a13a35f63</gtr:id><gtr:otherNames>Wang JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-3659</gtr:issn><gtr:outcomeId>585d72e7acf542.50519411</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB778895-B870-460F-932F-38A9FF7CCB22</gtr:id><gtr:title>Cationic poly-L-lysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>ACS nano</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb5d65786130fa33d5c7db8a4e025b56"><gtr:id>eb5d65786130fa33d5c7db8a4e025b56</gtr:id><gtr:otherNames>Al-Jamal KT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1936-0851</gtr:issn><gtr:outcomeId>54468e38255b03.35944358</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>520B3F36-2FDD-409A-B641-5F68CF2BF8E1</gtr:id><gtr:title>Production of water-soluble few-layer graphene mesosheets by dry milling with hydrophobic drug.</gtr:title><gtr:parentPublicationTitle>Langmuir : the ACS journal of surfaces and colloids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/977d58cc6b4175b5b854f5922c217c4f"><gtr:id>977d58cc6b4175b5b854f5922c217c4f</gtr:id><gtr:otherNames>Rubio N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0743-7463</gtr:issn><gtr:outcomeId>5675dcf08179a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E636A153-3A44-484D-8347-4B885B9767C4</gtr:id><gtr:title>Functionalized carbon nanotubes: revolution in brain delivery.</gtr:title><gtr:parentPublicationTitle>Nanomedicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c77de6f25ddbd82e1ab5917a13a35f63"><gtr:id>c77de6f25ddbd82e1ab5917a13a35f63</gtr:id><gtr:otherNames>Wang JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1743-5889</gtr:issn><gtr:outcomeId>5645e68949b743.71857935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEB18A27-B659-406F-8614-0F15ADD53939</gtr:id><gtr:title>Investigating the effect of tumor vascularization on magnetic targeting in&amp;Acirc;&amp;nbsp;vivo using retrospective design of experiment.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44dc7a52944d859e29834fdc1bcca804"><gtr:id>44dc7a52944d859e29834fdc1bcca804</gtr:id><gtr:otherNames>Mei KC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>585d3456931070.14666886</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69F57EC8-513A-4DDD-9CFE-A1F34A4D19CB</gtr:id><gtr:title>Cationic Liposome- Multi-Walled Carbon Nanotubes Hybrids for Dual siPLK1 and Doxorubicin Delivery In Vitro.</gtr:title><gtr:parentPublicationTitle>Pharmaceutical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdbc5d5447e5d5f6408c86864d743189"><gtr:id>fdbc5d5447e5d5f6408c86864d743189</gtr:id><gtr:otherNames>Pereira S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0724-8741</gtr:issn><gtr:outcomeId>5645e6bd8dafc1.62189864</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/J008656/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>17F21DBC-4946-4262-AD07-9914F6EA12F7</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Bioengineering</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>D22AE401-1C35-4706-A19C-10861ABC82CD</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biological membranes</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>7F6E0C83-7643-4C72-95C4-2160B6B43F14</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Bionanoscience</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>DC402B6E-3B84-4EAB-AED8-9CB51552A1CE</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Macro-molecular delivery</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>